Head And Neck Cancer

Hot tea consumption associated with increased esophageal cancer risk in high-risk individuals

1. Hot tea consumption in combination with excessive smoking or alcohol use was associated with a higher risk for esophageal cancer. 2. In the absence of excessive alcohol use and smoking, daily tea drinking was not linked to increased risk for esophageal cancer. Evidence Rating Level: 1 (Excellent)      Study Rundown: Esophageal cancer is a concern []

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

Oral Impairment Linked to Reduced QOL in Posttherapy Head and Neck Cancer

By

Study compared the effect of treatments on quality of life in treatment-naïve patients with HNC vs those who underwent radiotherapy and/or chemotherapy, and compared with cancer-free patients.

Radiotherapy for Esophageal Carcinoma: Dose, Response and Survival

[Cancer Management and Research] Radiation dose, fractionation strategies, and predictive factors of response to therapy in patients with esophageal carcinoma are reviewed to determine if more intense local therapy would lead to better outcomes and for which patients.

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer

By

In this study, researchers sought to determine the effect depressive symptoms during treatment planning had on immediate and long-term outcomes for patients with head and neck cancer.

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Lymph Node Density Helps Predict Thyroid Cancer Outcomes

Papillary thyroid cancer patients with LND 0.19 have worse disease-specific, overall survival, researchers found.

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Oral Microbiome Composition Linked to Esophageal Cancer Risk

Periodontal pathogen Tannerella forsythia linked to increased risk of esophageal adenocarcinoma

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

Survivors of Thyroid Cancer Have Higher Risk of Aging-related Morbidities

By

Using the statewide Utah Population Database, investigators sought to determine the long-term effects of thyroid cancer on survivors who were younger than 40 years at diagnosis.

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC

By

Data on psychosocial and psychiatric variables of patients with HNC prior to treatment was analyzed to determine the extent of cognitive impairment and quality of life for patients with head and neck cancer, and its impact on patient outcomes.

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

Age, Race, Sex Affect Survival for Patients With HPV-Associated Cancers

By

Using a data sample from the CDC National Program for Cancer Registries, investigators determined how demographic factors — age, race, and sex — impact 5-year survival rates for HPV-associated cancers from initial diagnosis until death.

Negative Margins, Lymph Node Yields Predict Survival

Negative Margins, Lymph Node Yields Predict Survival

Patients with head and neck cancer treated at hospitals attaining the combined metric of a 90 percent or higher negative margin rate and 80% percent of cases achieving a LNY of 18 or more experienced a significant reduction in mortality.

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

De-escalated Radiation Therapy Improves Quality of Life in Throat Cancer

By

Aggressive de-escalation of chemoradiation after surgery in patients with HPV-associated OPSCC led to similar disease control and improved quality of life and safety profile compared with historical controls, according to data presented at the ASTRO 59th Annual Meeting.

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

Distress Assessments Improve Psychosocial Support Referrals for HNC Patients

By By By

A quality improvement project demonstrates that routine distress assessment using the NCCN DT/PL in patients with head and neck cancers improves referrals for psychosocial services.

Most Skull Radiation Patients Show No Cognitive Impairment

Most Skull Radiation Patients Show No Cognitive Impairment

The researchers found that the majority of patients had no frank detectable cognitive impairment after undergoing skull base irradiation.

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

Resistance Training, Nutritional Interventions Prevent Muscle Loss During, After Radiotherapy for Head and Neck Cancer

By

Intervention with resistance training and nutritional supplements during and after radiation therapy is not only feasible, but also shown to prevent loss of muscle mass and improve quality of life in patients with head and neck cancer (HNC).

Risk of Thyroid Cancer Increased With Fruit Juice Consumption, No Effect With Fruit and Vegetable Consumption

Risk of Thyroid Cancer Increased With Fruit Juice Consumption, No Effect With Fruit and Vegetable Consumption

By

No correlation was found between fruit and vegetable consumption and the risk of differentiated thyroid cancer, but a positive trend may be associated with fruit juice intake.

Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients

Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients

By

Results from a sub-analysis of the impact of age on the safety and efficacy of lenvatinib in patients with RR-DTC in the SELECT trial showed that lenvatinib significantly increased PFS.

Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma

Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma

By

Immunotherapy regimens FDA-approved for the treatment of melanoma may also be an option for a rare and aggressive form of papillary thyroid cancer.

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

Pembrolizumab Use With CRT Safe in Locally Advanced HNSCC

By

Small study also showed that pembrolizumab does not significant impair radiation or chemotherapy dosing.

Adjuvant + Neoadjuvant Pembrolizumab Safe in Patients Undergoing HNSCC Surgery

Adjuvant + Neoadjuvant Pembrolizumab Safe in Patients Undergoing HNSCC Surgery

By

Study also provides evidence supporting an anti-tumor effect associated with a single preoperative dose of pembrolizumab.

ESW Technique Improves Nanoparticle Drug Delivery to Solid Tumors with Restricted Blood Flow

ESW Technique Improves Nanoparticle Drug Delivery to Solid Tumors with Restricted Blood Flow

By

Combining extracorporeal shock wave (ESW) technique with nanoparticle delivery improves treatment of difficult-to-treat solid tumors, such as anaplastic thyroid cancer.

The United States Services Task Force (USPSTF) Recommends Against Thyroid Cancer Screening

The United States Services Task Force (USPSTF) Recommends Against Thyroid Cancer Screening

By

Although screening is often recommended as the first line of prevention for most cancers, recent recommendation from the USPSTF advises against thyroid cancer screening in nonsymptomatic adults.

Survivorship Care Plans Specific to Head and Neck Cancers Enable Transition to Posttreatment Care

Survivorship Care Plans Specific to Head and Neck Cancers Enable Transition to Posttreatment Care

By

Disease-specific survivorship care plans (SCPs) for head and neck cancer support a successful transition to a healthy lifestyle after curative intent therapy of larynx and oral cavity/pharynx cancer.

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

Education and Coaching Are Necessary to Treat Oropharyngeal Cancers After Chemoradiotherapy

By

A literature review noted improvements in quality of life after patients were coached and educated following radiotherapy for HPV-associated oropharyngeal cancers.

ASTRO Guideline Addresses Curative Treatment of Oropharyngeal Cancer

ASTRO Guideline Addresses Curative Treatment of Oropharyngeal Cancer

By

Clinical practice guideline from ASTRO addresses optimal radiation doses and fractionation schedules, integrating therapies, and induction chemotherapy for oropharyngeal squamous cell carcinoma (OPSCC).

Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer

Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer

By

Thyroid is more likely to be managed with surgical intervention when patients have access to expanded health insurance.

Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations

Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations

By

A report on incidence of thyroid cancer shows incidence of the disease is increasing among certain populations: younger persons, Hispanic, and African American.

Continuing Nivolumab After Progression of Head and Neck Cancer May Improve Survival

Continuing Nivolumab After Progression of Head and Neck Cancer May Improve Survival

By

Continuing immunotherapy after disease progression extends survival for some patients with head and neck cancer.

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

Presence of Protein E6 Predictive of Oropharyngeal Cancer Risk in HPV16-Infected Persons

By

Protein produced by chronically infected cells in persons with HPV16 infection serves as a biomarker for risk of cancer of the oropharynx.

Thymomas Trigger Newly Described Autoimmune Endocrine Disease

Thymomas Trigger Newly Described Autoimmune Endocrine Disease

By

Thymomas can result in a newly described autoimmune disease, potentially leading to hypopituitarism,

No Intervention for Small Thyroid Cancers May Cause Anxiety

No Intervention for Small Thyroid Cancers May Cause Anxiety

By

Deciding not to intervene for small, incidentally identified thyroid cancer may cause patients to experience anxiety and feelings of isolation.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs